Secukinumab (Cosentyx, Novartis) should be available on the NHS in England as a treatment option for moderate-to-severe hidradenitis suppurativa, the National Institute for Health and Care Excellence ...
Baoxi Wang, Wei Yang, Wen Wen, Jing Sun, Bin Su, Bo Liu, Donglai Ma, Dan Lv, Yaran Wen, Tao Qu, Min Chen, Miao Sun, Yan Shen, Xue Zhang https://www.jstor.org/stable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback